Biocon Q3 profit zooms twofold to Rs 217 crore
Consolidated revenue from operations stood at Rs 1,540.8 crore for the quarter, against Rs 1,057.9 crore.
By PTI |
Getty Images
New Delhi: Biotechnology major Biocon Thursday reported over twofold jump in consolidated net profit to Rs 217.2 crore for the third quarter ended December 2018, mainly on account of strong performance of its biologics business.
The company had posted a net profit of Rs Rs 91.9 crore for the corresponding period of the previous fiscal, Biocon said in a filing to the BSE.
Its consolidated revenue from operations stood at Rs 1,540.8 crore for the quarter, against Rs 1,057.9 crore, it added.
Shares of Biocon Ltd closed at Rs 670.55 per scrip on the BSE, up 0.04 per cent from the previous close.
The company had posted a net profit of Rs Rs 91.9 crore for the corresponding period of the previous fiscal, Biocon said in a filing to the BSE.
Its consolidated revenue from operations stood at Rs 1,540.8 crore for the quarter, against Rs 1,057.9 crore, it added.
Shares of Biocon Ltd closed at Rs 670.55 per scrip on the BSE, up 0.04 per cent from the previous close.
Too busy to trade in stocks? Invest in Mutual Funds with ET Money!
Bookmark or read stories offline -
Download ET Markets APP
Download ET Markets APP
Related Articles
Biocon Q3 Results: PAT at Rs 660 crore vs Rs 42-crore loss a year agoADVERTISEMENT
